ImThera Medical Completes Enrollment in Multi-center Study of the aura6000™ System for Obstructive Sleep Apnea

THN2 Study Will Expand the Clinical Evidence for this Innovative Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea. SAN DIEGO and VANCOUVER, British Columbia, Sept. 30, 2013 /PRNewswire/ — ImThera Medical, Inc. a privately held global medical device company, today announced that the final patient has been implanted in its THN2 (Targeted Hypoglossal Neurostimulation #2) study. The THN2 […]